Navigation Links
Global Market for Minimally Invasive Vertebral Compression Fracture Treatments Will Reach $925 Million by 2022
Date:9/3/2014

BURLINGTON, Mass., Sept. 3, 2014 /PRNewswire/ -- Decision Resources Group finds that the global market for minimally invasive vertebral compression fracture (MIVCF) treatments will reach a value of $925 million by 2022, driven by an increasing prevalence of osteoporosis, which is largely the result of an aging population. In addition, marketing activity and positive clinical data will spur increasing use of these devices in the tumor and trauma indications, supporting overall procedure volumes.

Other key findings from Decision Resources Group's coverage of the global MIVCF treatment market:

  • Global price declines: Price competition and economic challenges will negatively impact average device prices. Financial concerns will be particularly evident in European countries such as Italy, where the effects of the eurozone crisis are still lingering.
  • Rapidly expanding revenues in Japan: The Japanese market will see the strongest revenue growth, driven by the recent reimbursement approval and subsequent rapid adoption of Medtronic's Kyphoplasty product in the vertebral augmentation segment.
  • Steady U.S. forecast: Despite issues with reimbursement that hindered procedure volume growth in 2013, the United States market will remain the largest but lowest growth market through 2022; currently this market represents approximately two-thirds of total global revenues.

Comments from Decision Resources Group Senior Analyst Brady Baker:

  • "Medtronic holds the majority of revenues in the global MIVCF treatment market, largely as a result of its stronghold in the vertebral augmentation space. Additional competitors will look to capture market share, however, by launching innovative and lower-cost products. For example, both CareFusion and DFINE have gained strong market shares by incorporating unique features and low price points into their product portfolios."

Comments from Decision Resources Group Analyst Valentina Lim:

  • "Poor or nonexistent reimbursement will limit overall revenue expansion in some markets. For example, unfavorable reimbursement for vertebroplasty—particularly in Australia and Japan—will somewhat limit growth in the Asia Pacific region."

Additional Resources:

About Decision Resources Group

Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. Clients rely on this analysis and data to make informed decisions. Find out more at www.DecisionResourcesGroup.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Decision Resources Group 
Christopher Comfort  
781-993-2597  
ccomfort@dresourcesgroup.com

Logo - http://photos.prnewswire.com/prnh/20130103/MM36768LOGO


'/>"/>
SOURCE Decision Resources Group
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Bone Cement and Accessories Market Is Set to Expand from $630 Million in 2013 to Over $1 Billion by 2022
2. Cambrex To Present At Rodman & Renshaw 16th Annual Global Investment Conference
3. CytoSorbents to Present at the 2014 Rodman & Renshaw Annual Global Investment Conference
4. Isis Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference
5. RXi Pharmaceuticals to Present at the Rodman & Renshaw 16th Annual Global Investment Conference
6. Relmada Therapeutics to Present at the 16th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th, 2014
7. Infinity And AbbVie Announce Global Strategic Collaboration To Develop And Commercialize Duvelisib (IPI-145) In Oncology
8. Global Markets and Technologies for Molecular Imaging Devices
9. Bariatric Surgery: Global Markets for Services and Devices
10. Acute Heart Failure Global Clinical Trials Review, H2, 2014
11. Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical Systems ... "Company"), which develops, markets and sells medical devices and ... , signed a strategic cooperation agreement with Hongyuan Supply ... Supply Chain") on June 20, 2016, to develop Dehaier,s ... strategic cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Market - Forecast to 2022" report to their offering. ... method for the patients with kidney failure, it replaces the ... from the patient,s blood and thus the treatment helps to ... chloride in balance. Increasing number of ESRD ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice ... "Film editors can give their videos a whole new perspective by using the ... of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets to ...
(Date:6/25/2016)... ... 2016 , ... Experts from the American Institutes for Research ... June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR experts ... planning, healthcare costs and patient and family engagement. , AIR researchers will be ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
Breaking Medicine News(10 mins):